banner

AmeraMex Receives $500,000 Worth of Orders from South America

AmeraMex International (AMMX)

Chico, California-based AmeraMex International, Inc. (Pink Sheets: AMMX), a provider of heavy equipment to logistics companies, infrastructure construction, commercial farming and mining companies, announced it has received additional orders totaling $500,000 for heavy equipment from its South American customers. The equipment is in inventory and is expected to ship before the end of May.

In March, AmeraMex received orders totally approximately $1.7 million from South America.



“South American countries are resource rich and busy exporting to other growth countries such as China, Russia and India,” said AmeraMex CEO Lee Hamre.  “Countries such as Peru, Panama, Brazil and Chile are expecting growth rates from 9.8 percent to 6.78 percent and an International Monetary Fund economist projects overall growth in South America to be 3.7 percent for 2012 and 4.1 percent for 2013. We are developing a strong customer base in South America and look forward to expanding our outreach as we grow revenue.”

The company is also pursuing additional clients in Africa, a market that AmeraMex believes has “tremendous opportunities,” according to today’s press.  Economists are calling for a 6 percent growth rate for Africa in 2012, despite significant challenges across many of its countries.

A Pink Sheet company, AmeraMex said last month that a two-year audit is being finalized.  The 2011 audit was completed with the company reporting full year revenue of $5.22 million, a 53 percent increase over unaudited 2010 revenue of $3.35 million.  Net profit totaled $152,850 in 2011 as compared to a net loss of $322,503 in 2010.  The company has 388 million shares outstanding and a market cap of $5.3 million currently.

AmeraMex (AMMX) Stock Quote and News:







Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0)

Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0)

One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact.

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0)

Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing

Men’s Health Features Naked Brand Group Line of Underwear

Men’s Health Features Naked Brand Group Line of Underwear(0)

Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.”  The guide was published on MensHealth.com on March 20.  This is the second time the company has been featured in the men’s mag in as

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0)

Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General

read more
banner


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.